Colgate-Palmolive Q3 beat prompts higher 2026 EPS guidance
Solid beat and higher 2026 profitability outlook can support multiple expansion; small pre-market move suggests limited immediate reaction, but rising targets imply longer upside potential.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Solid beat and higher 2026 profitability outlook can support multiple expansion; small pre-market move suggests limited immediate reaction, but rising targets imply longer upside potential.
What happened, with direct paths to the underlying reporting
Colgate-Palmolive delivered a Q3 beat with Base Business EPS of 97c, up 7%, and sales of $5.369B, up 4.6%. The company narrowed 2026 net sales growth to 4-5% while lifting Base Business EPS growth to 5-7%, signaling improved profitability amid macro headwinds. Analysts modestly raised targets, and the stock traded slightly higher in pre-market action.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.